Drug Approval | September 29, 2023
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
InvaGen has received 5 inspectional observations in Form 483
The inspection was a cGMP Inspection and had ended with NIL observations
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right_256_384.jpg)
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Eris Lifesciences enters into term loan agreement with Citi Bank
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
Subscribe To Our Newsletter & Stay Updated
